載入...
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors
Malignant brain tumors, including gliomas, brain metastases and anaplastic meningiomas, are associated with poor prognosis, and represent an unmet medical need. ASA404 (DMXAA), a vascular disrupting agent, has demonstrated promising results in several preclinical tumor models and early phase clinica...
Na minha lista:
| 發表在: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5652230/ https://ncbi.nlm.nih.gov/pubmed/29098034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6832 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|